Approaches to handling data when a phase II trial deviates from the pre‐specified Simon's two‐stage design
暂无分享,去创建一个
[1] Sin-Ho Jung,et al. Admissible two‐stage designs for phase II cancer clinical trials , 2004, Statistics in medicine.
[2] T R Fleming,et al. One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.
[3] Weichung Joe Shih,et al. Group sequential, sample size re‐estimation and two‐stage adaptive designs in clinical trials: a comparison , 2006, Statistics in medicine.
[4] R. Simon,et al. Optimal two-stage designs for phase II clinical trials. , 1989, Controlled clinical trials.
[5] D. Sargent,et al. A three-outcome design for phase II clinical trials. , 2001, Controlled Clinical Trials.
[6] S. Green,et al. Planned versus attained design in phase II clinical trials. , 1992, Statistics in medicine.
[7] D. Redden,et al. Stochastically curtailed phase II clinical trials , 2007, Statistics in medicine.
[8] Sin-Ho Jung,et al. p-Value Calculation for Multistage Phase II Cancer Clinical Trials , 2006, Journal of biopharmaceutical statistics.
[9] A A Tsiatis,et al. Exact confidence intervals following a group sequential test. , 1984, Biometrics.
[10] Weichung J Shih,et al. Adaptive Two‐Stage Designs for Single‐Arm Phase IIA Cancer Clinical Trials , 2004, Biometrics.
[11] R Simon,et al. Data monitoring committees and problems of lower-than-expected accrual or events rates. , 1996, Controlled clinical trials.
[12] R. Wittes,et al. Research Methods in Clinical Oncology , 1988 .